SCAN 2019
This autumn the International Neuroendocrine Cancer Alliance INCA invites NET patients and healthcare professionals to scan the access challenges to optimal care for NET patients.
Recent News
Mental Health Outreach Campaign
November 10th was World Neuroendocrine Cancer Day. Assumed rare, Neuroendocrine Cancer is now the 10th most prevalent Cancer in England, with a continually rising incidence - that has already seen a 371% increase since 1995. Despite this increase, low awareness and...
Patient advocacy in action: discussion with Mark McDonnell
24th October 2022 Mark McDonnell is Chairperson of the NET Patient Network in Ireland and President of the International Neuroendocrine Cancer Alliance (INCA). Neuroendocrine neoplasms are classified as an orphan disease, meaning they affect a small portion of the...
UK Clinical ‘Trials that Matter’
As many of you will know, Neuroendocrine Cancer UK is a member of INCA (the International Neuroendocrine Cancer Alliance). INCA is the global voice for patients with Neuroendocrine Cancer, with a mission to raise awareness, push for scientific advancements, focus on...